Silence Therapeutics plc (SLN) Net margin 2022–2025
Silence Therapeutics plc (SLN) net profit margin by fiscal year — reported net income divided by reported revenue.
-15851.9%FY2025 · since FY2022: -232.4% → -15851.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -15851.9% | -15747.1 pp |
| FY2024 | -104.7% | +66.6 pp |
| FY2023 | -171.4% | +61.1 pp |
| FY2022 | -232.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice